Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node-Negative, p53-Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma. | Arch Pathol Lab Med | 2023 | 35862858 | PubTator, text mining | PubMed |
| Vitamin D modulates inflammatory response of DENV-2-infected macrophages by inhibiting the expression of inflammatory-liked miRNAs. | Pathog Glob Health | 2023 | 35850625 | PubTator, text mining | PubMed |
| PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion. | Haematologica | 2023 | 35833296 | PubTator, text mining | PubMed |
| Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors. | Arch Pathol Lab Med | 2023 | 35671167 | PubTator, text mining | PubMed |
| Helicobacter pylori Immune Response in Children Versus Adults. | Med Res Arch | 2022 | 37936946 | PubTator, text mining | PubMed |
| Tumor hijacks macrophages and microbiota through extracellular vesicles. | Exploration (Beijing) | 2022 | 37324578 | PubTator, text mining | PubMed |
| Role of B7 family members in glioma: Promising new targets for tumor immunotherapy. | Front Oncol | 2022 | 36741734 | PubTator, text mining | PubMed |
| Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma. | Front Immunol | 2022 | 36733399 | PubTator, text mining | PubMed |
| Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2022 | 36714595 | PubTator, text mining | PubMed |
| Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer. | Front Oncol | 2022 | 36713553 | PubTator, text mining | PubMed |
| A signature-based classification of lung adenocarcinoma that stratifies tumor immunity. | Front Oncol | 2022 | 36713530 | PubTator, text mining | PubMed |
| Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis. | Front Cell Dev Biol | 2022 | 36712973 | PubTator, text mining | PubMed |
| Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment. | Front Oncol | 2022 | 36698392 | PubTator, text mining | PubMed |
| Prognostic value of FOXP3+ regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis. | BMJ Open | 2022 | 36691128 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis. | Front Oncol | 2022 | 36686830 | PubTator, text mining | PubMed |
| Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer. | Front Genet | 2022 | 36685937 | PubTator, text mining | PubMed |
| Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis. | Front Immunol | 2022 | 36685512 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma. | Front Immunol | 2022 | 36685508 | PubTator, text mining | PubMed |
| Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer. | Front Surg | 2022 | 36684237 | PubTator, text mining | PubMed |
| Macrophages as a Potential Immunotherapeutic Target in Solid Cancers. | Vaccines (Basel) | 2022 | 36679900 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=28